Study | Year | Country or Region | Study type | Number of patients | Median follow-up months | Subtype | Chemotherapya | Radiotherapyb | Outcomesc |
---|---|---|---|---|---|---|---|---|---|
Magee B [37] | 1996 | United Kingdom | Prospective | 708 | 96 | Not mentioned | No | Mixed | BR (LR) |
Dinshaw KA [25] | 2005 | India | Retrospective | 1022 | 53 | All | Adjuvant | Yes | OS/DFS/LRR/DM/LR |
Yoshida T [38] | 2009 | Japan | Retrospective | 2243 | 64.7 | All | Adjuvant | Mixed | DM |
Yi O.V. [39] | 2009 | Korea | Retrospective | 578 | 54.1 | All | Mixed | Yes | LR |
Lupe K [40] | 2011 | Canada | Retrospective | 2264 | 62.4 | All | Not mentioned | Yes | LR |
Adkins FC [41] | 2011 | America | Retrospective | 1325 | 62 | TNBC | Adjuvant | Mixed | LRR |
Freedman GM [42] | 2012 | Brazil | Prospective | 1478 | 68 | All | Mixed | Yes | OS |
Mittendorf EA [43] | 2013 | America | Prospective | 2983 | 94.8 | All | Mixed | Yes | LRR |
Perez CA [44] | 2013 | America | Retrospective | 704 | 51 | TNBC | Adjuvant | Mixed | OS/LRR/DM |
Matsuda N [45] | 2014 | Japan | Retrospective | 622 | 51 | All | Neoadjuvant | Yes | LRR |
Park JS [46] | 2015 | Korea | Retrospective | 1071 | 114 | All | Adjuvant | Mixed | DFS/BCSS (DSS) |
Sopik V[47] | 2015 | Canada | Retrospective | 1675 | 157.2 | All | Mixed | Mixed | BCSS (DSS)/LR |
Nichol AM[26] | 2017 | Canada | Retrospective | 1034 | 151.2 | HR +  | Not mentioned | Half patients received | OS/EFS |
Lee BM[27] | 2018 | Korea | Retrospective | 2206 | 73 | All | Mixed | Yes | OS |
Chen SY[28] | 2018 | China | Retrospective | 1791 | 50.4 | All | Adjuvant | Yes | OS/DFS/LRR/DM |